Clinical trial
Phase 3 Clinical Trial - Efficacy and Safety Evaluation of the Drug Imescard Compound Water Smartweed, Adrenalin and Hamamelis Ointment
NCT00935948 is registered in ClinicalTrials.gov with Hospital de Clinicas de Porto Alegre as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 3 Clinical Trial - Efficacy and Safety Evaluation of the Drug Imescard Compound Water Smartweed, Adrenalin and Hamamelis Ointment
- Lead sponsor
- Hospital de Clinicas de Porto Alegre
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- April 30, 2008
- Completion date
- Not reported
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hemorrhoidal disease